Find latest Breast videos · 400+ videos
Total Health
Avatar

62 y/o With HER2+ mBC Who Underwent 2L TDXd Therapy: Case Presentation and Panel Discussion

By Total Health FEATURING Priyanka Sharma, Melinda Telli, Kevin Kalinsky
By Total Health FEATURING Priyanka Sharma, Melinda Telli, Kevin Kalinsky
454 views
March 15, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

03:38
Lilly Medical Affairs

SERDS: Relevance and Role in Current & Future Treatments for HR+…

Feat. K. Jhaveri

Related Videos

25:08

ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice

2024 ASCO® Annual Meeting Insights Hub

S. Tolaney, H. Rugo

4.3K views
08:49

ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-…

2024 ESMO Annual Meeting Insights Hub

K. Natsuhara

851 views
06:51

SABCS 2024 Noteworthy Abstracts in Metastatic Breast Cancer

Sara Tolaney

H. Rugo

529 views
14:52

ESMO 2024 Summary: Top 5 Breast Cancer Abstracts - NATALEE, DESTINY-…

2024 ESMO Annual Meeting Insights Hub

P. Tarantino

838 views
20:32

ESMO 2024 Summary: mBC Panel Discussion on Key Studies - DESTINY-Bre…

2024 ESMO Annual Meeting Insights Hub

S. Tolaney, H. Rugo

556 views
21:34

The 2023 ASCO®/CAP Guideline Update on HER2 Testing/Classification: …

Shabnam Jaffer

739 views
20:25

ESMO 2024 Summary: Highlights in mBC

2024 ESMO Annual Meeting Insights Hub

G. Bianchini

533 views
29:24

ESMO 2024 Summary: Breast Cancer Highlights - AURORA Program, DAISY …

2024 ESMO Annual Meeting Insights Hub

C. Sotiriou

542 views
04:03

Trastuzumab Deruxtecan's Efficacy Across HER2 Expression Levels in m…

Fernanda Mosele

370 views
36:18

Metastatic Breast Cancer Comprehensive Review: ESMO Breast 2024 Awar…

Insights from ESMO Breast 2024 Annual Meeting

H. Rugo

1.2K views
33:44

ASCO® 2024 Expert Recap: "Metastatic Breast Cancer Deep Dive & Clini…

2024 ASCO® Annual Meeting Insights Hub

S. Tolaney, H. Rugo

929 views
11:54

ESMO 2024 Summary: Management of Oligoprogressive Disease - Patients…

2024 ESMO Annual Meeting Insights Hub

R. Van den Begin

460 views
19:15

Benefits of Oral Formulations in HR+/HER2- mBC: Reducing Time Toxici…

Priya Tiwari

488 views
12:35

SABCS 2023 Summary: "What Is the Appropriate 1L Therapy for ER+ mBC?"

Insights from 2023 SABCS

S. Tolaney, H. Rugo

3.0K views
15:25

Evolution of Treatment Algorithms for HER2+ mBC

RWJBarnabas Health Rutgers Cancer Institute of New Jersey

M. George

362 views
35:39

Clinical Roundtable: HR+ BC Early Stage & Metastatic Disease Updates

Integrity CE

S. Graff, S. Dent, S. Gandhi

238 views
14:16

Year in Review: Breast Cancer

Dana-Farber Cancer Institute

P. Tarantino

2.4K views
23:59

Serial CDK4/6 Inhibitor Therapy for HR+-HER2- MBC: Evolving Insights…

Seth Wander

537 views
11:05

ESMO 2024 Insights: DESTINY-Breast06 Trial - HER2-Low and HER2-Ultra…

2024 ESMO Annual Meeting Insights Hub

G. Viale

363 views
10:34

ASCO® 2024 Noteworthy Abstracts in Breast Cancer

Sara Tolaney

H. Rugo

932 views
AUTOPLAY